ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Fritzsche, Florian R ^a,b   Wassermann, Kirsten ^a   Jung, Monika ^a   Tölle, Angelika ^a   Kristiansen, Ilka ^a   Lein, Michael ^a   Johannsen, Manfred ^a   Dietel, Manfred ^a   Jung, Klaus ^a   Kristiansen, Glen ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM9 PROTEIN; MESSENGER RNA; ADAM9 PROTEIN, HUMAN; MEMBRANE PROTEIN; RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR GROWTH; UNIVARIATE ANALYSIS; UPREGULATION; BIOSYNTHESIS; DISEASE COURSE; DISEASE FREE SURVIVAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; UP-REGULATION;

EID: 47349104126     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-179     Document Type: Article

References (52)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA: A cancer journal for clinicians 2007, 57(1):43-66. 17237035
2. McLaughlin JK Lipworth L Epidemiologic aspects of renal cell cancer Seminars in oncology 2000, 27(2):115-123. 10768591
3. Dhote R Pellicer-Coeuret M Thiounn N Debre B Vidal-Trecan G Risk factors for adult renal cell carcinoma: A systematic review and implications for prevention BJU international 2000, 86(1):20-27. 10886077
4. Dall'Oglio MF Arap MA Antunes AA Cury J Leite KR Srougi M Impact of clinicopathological parameters in patients treated for renal cell carcinoma The Journal of urology 2007, 177(5):1687-1691. 17437783
5. Breda A Konijeti R Lam JS Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection Expert review of anticancer therapy 2007, 7(6):847-862. 17555395
6. Martignoni G Brunelli M Gobbo S Remo A Ficarra V Cossu-Rocca P Pea M Chilosi M Menestrina F Cheng L Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Analytical and quantitative cytology and histology Anal Quant Cytol Histol 2007, 29(1):41-49. 17375873
7. Rathmell WK Martz CA Rini BI Renal cell carcinoma Current opinion in oncology 2007, 19(3):234-240. 17414642
8. Young AN Master VA Amin MB Current trends in the molecular classification of renal neoplasms The Scientific World Journal 2006, 6:2505-2518.
9. Hammond ME Fitzgibbons PL Compton CC Grignon DJ Page DL Fielding LP Bostwick D Pajak TF College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants Archives of pathology & laboratory medicine 2000, 124(7):958-965. 10888771
10. Yamamoto S Higuchi Y Yoshiyama K Shimizu E Kataoka M Hijiya N Matsuura K ADAM family proteins in the immune system Immunology today 1999, 20(6):278-284. 10354553
11. Bjarnason JB Fox JW Snake venom metalloendopeptidases: Reprolysins Methods in enzymology 1995, 248:345-368. 7674931
12. Wolfsberg TG Primakoff P Myles DG White JM ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions The Journal of cell biology 1995, 131(2):275-278. 2199973 7593158
13. Iba K Albrechtsen R Gilpin BJ Loechel F Wewer UM Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion The American journal of pathology 1999, 154(5):1489-1501. 1866592 10329602
14. Nath D Slocombe PM Stephens PE Warn A Hutchinson GR Yamada KM Docherty AJ Murphy G Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells Journal of cell science 1999, 112(Pt 4):579-587. 9914169
15. Nath D Slocombe PM Webster A Stephens PE Docherty AJ Murphy G Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility Journal of cell science 2000, 113(Pt 12):2319-2328. 10825303
16. Schwettmann L Tschesche H Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin Protein Expr Purif 2001, 21(1):65-70. 11162388
17. Zhou M Graham R Russell G Croucher PI MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin Biochem Biophys Res Commun 2001, 280(2):574-580. 11162558
18. Carl-McGrath S Lendeckel U Ebert M Roessner A Rocken C The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer International journal of oncology 2005, 26(1):17-24. 15586220
19. Grutzmann R Foerder M Alldinger I Staub E Brummendorf T Ropcke S Li X Kristiansen G Jesnowski R Sipos B Gene expression profiles of microdissected pancreatic ductal adenocarcinoma Virchows Arch 2003, 443(4):508-517. 12942322
20. Grutzmann R Luttges J Sipos B Ammerpohl O Dobrowolski F Alldinger I Kersting S Ockert D Koch R Kalthoff H ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma British journal of cancer 2004, 90(5):1053-1058. 14997207
21. Hirao T Nanba D Tanaka M Ishiguro H Kinugasa Y Doki Y Yano M Matsuura N Monden M Higashiyama S Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells Experimental cell research 2006, 312(3):331-339. 16336960
22. Karan D Lin FC Bryan M Ringel J Moniaux N Lin MF Batra SK Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas International journal of oncology 2003, 23(5):1365-1371. 14532978
23. Kristiansen G Pilarsky C Wissmann C Kaiser S Bruemmendorf T Roepcke S Dahl E Hinzmann B Specht T Pervan J Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival The Journal of pathology 2005, 205(3):359-376. 15532095
24. Lendeckel U Kohl J Arndt M Carl-McGrath S Donat H Rocken C Increased expression of ADAM family members in human breast cancer and breast cancer cell lines Journal of cancer research and clinical oncology 2005, 131(1):41-48.
25. O'Shea C McKie N Buggy Y Duggan C Hill AD McDermott E O'Higgins N Duffy MJ Expression of ADAM-9 mRNA and protein in human breast cancer Int J Cancer 2003, 105(6):754-761. 12767059
26. Yamada D Ohuchida K Mizumoto K Ohhashi S Yu J Egami T Fujita H Nagai E Tanaka M Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer Anticancer research 2007, 27(2):793-799. 17465204
27. Zigrino P Mauch C Fox JW Nischt R Adam-9 expression and regulation in human skin melanoma and melanoma cell lines Int J Cancer 2005, 116(6):853-859. 15856464
28. Ding X Yang LY Huang GW Wang W Lu WQ ADAM17 mRNA expression and pathological features of hepatocellular carcinoma World J Gastroenterol 2004, 10(18):2735-2739. 15309730
29. Le Pabic H Bonnier D Wewer UM Coutand A Musso O Baffet G Clement B Theret N ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling Hepatology 2003, 37(5):1056-1066. 12717386
30. McCulloch DR Akl P Samaratunga H Herington AC Odorico DM Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP Clin Cancer Res 2004, 10(1 Pt 1):314-323. 14734484
31. Tannapfel A Anhalt K Hausermann P Sommerer F Benicke M Uhlmann D Witzigmann H Hauss J Wittekind C Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays The Journal of pathology 2003, 201(2):238-249. 14517841
32. Tian BL Wen JM Zhang M Xie D Xu RB Luo CJ The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone Mol Pathol 2002, 55(6):394-397. 1187278 12456779
33. Roemer A Schwettmann L Jung M Roigas J Kristiansen G Schnorr D Loening SA Jung K Lichtinghagen R Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome Oncology reports 2004, 11(2):529-536. 14719095
34. Roemer A Schwettmann L Jung M Stephan C Roigas J Kristiansen G Loening SA Lichtinghagen R Jung K The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers? The Journal of urology 2004, 172(6 Pt 1):2162-2166. 15538223
35. Izumi Y Hirata M Hasuwa H Iwamoto R Umata T Miyado K Tamai Y Kurisaki T Sehara-Fujisawa A Ohno S A metalloprotease-disintegrin, MDC9/ meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor The EMBO journal 1998, 17(24):7260-7272. 1171072 9857183
36. Roghani M Becherer JD Moss ML Atherton RE Erdjument-Bromage H Arribas J Blackburn RK Weskamp G Tempst P Blobel CP Metalloprotease-disintegrin MDC9: Intracellular maturation and catalytic activity The Journal of biological chemistry 1999, 274(6):3531-3540. 9920899
37. Tanaka M Nanba D Mori S Shiba F Ishiguro H Yoshino K Matsuura N Higashiyama S ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands The Journal of biological chemistry 2004, 279(40):41950-41959. 15280379
38. Normanno N Bianco C Strizzi L Mancino M Maiello MR De Luca A Caponigro F Salomon DS The ErbB receptors and their ligands in cancer: An overview Current drug targets 2005, 6(3):243-257. 15857286
39. Normanno N De Luca A Bianco C Strizzi L Mancino M Maiello MR Carotenuto A De Feo G Caponigro F Salomon DS Epidermal growth factor receptor (EGFR) signaling in cancer Gene 2006, 366(1):2-16. 16377102
40. Higashiyama S Nanba D ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk Biochimica et biophysica acta 2005, 1751(1):110-117. 16054021
41. Tanida S Joh T Itoh K Kataoka H Sasaki M Ohara H Nakazawa T Nomura T Kinugasa Y Ohmoto H The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells Gastroenterology 2004, 127(2):559-569. 15300588
42. Mahimkar RM Visaya O Pollock AS Lovett DH The disintegrin domain of ADAM9: A ligand for multiple beta1 renal integrins The Biochemical journal 2005, 385(Pt 2):461-468. 1134717 15361064
43. Kristiansen G Yu Y Petersen S Kaufmann O Schluns K Dietel M Petersen I Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer Eur J Cancer 2001, 37(9):1089-1095. 11378338
44. Schroeder A Mueller O Stocker S Salowsky R Leiber M Gassmann M Lightfoot S Menzel W Granzow M Ragg T The RIN: An RNA integrity number for assigning integrity values to RNA measurements BMC molecular biology 2006, 7:3. 1413964 16448564
45. Jung M Ramankulov A Roigas J Johannsen M Ringsdorf M Kristiansen G Jung K In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR BMC molecular biology 2007, 8:47. 1913536 17559644
46. Ohl F Jung M Radonic A Sachs M Loening SA Jung K Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer The Journal of urology 2006, 175(5):1915-1920. 16600798
47. Vandesompele J De Preter K Pattyn F Poppe B Van Roy N De Paepe A Speleman F Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome biology 2002, 3:7. RESEARCH0034 126239 12184808
48. Alldinger I Dittert D Peiper M Fusco A Chiappetta G Staub E Lohr M Jesnowski R Baretton G Ockert D Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer Pancreatology 2005, 5(4-5):370-379. 15983444
49. Shigemura K Sung SY Kubo H Arnold RS Fujisawa M Gotoh A Zhau HE Chung LW Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells The Prostate 2007, 67(7):722-731. 17342749
50. Shintani Y Higashiyama S Ohta M Hirabayashi H Yamamoto S Yoshimasu T Matsuda H Matsuura N Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis Cancer research 2004, 64(12):4190-4196. 15205330
51. Peduto L Reuter VE Shaffer DR Scher HI Blobel CP Critical function for ADAM9 in mouse prostate cancer Cancer research 2005, 65(20):9312-9319. 16230393
52. Sung SY Kubo H Shigemura K Arnold RS Logani S Wang R Konaka H Nakagawa M Mousses S Amin M Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells Cancer research 2006, 66(19):9519-9526. 17018608